Trial Profile
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase IIb, Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2019
Price :
$35
*
At a glance
- Drugs DHP 1401 (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms DRAMA
- Sponsors Daehwa Pharmaceutical
- 22 Jul 2019 Status changed from recruiting to completed.
- 29 Aug 2018 Planned End Date changed from 1 Sep 2018 to 1 Jun 2019.
- 29 Aug 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Mar 2019.